Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

2.
3.

Lovastatin and simvastatin prevention studies.

Jones PH.

Am J Cardiol. 1990 Sep 18;66(8):39B-43B. Review.

PMID:
2206035
5.

Retardation of coronary atherosclerosis: the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) and other angiographic trials.

de Faire U, Ericsson CG, Grip L, Nilsson J, Svane B, Hamsten A.

Cardiovasc Drugs Ther. 1997 May;11 Suppl 1:257-63. Review.

PMID:
9211018
6.

Secondary preventive potential of lipid-lowering drugs. The Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).

de Faire U, Ericsson CG, Grip L, Nilsson J, Svane B, Hamsten A.

Eur Heart J. 1996 Dec;17 Suppl F:37-42. Review.

PMID:
8960446
7.
8.
9.

-455G/A polymorphism of the beta-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: proposed role for an acute-phase reaction pattern of fibrinogen. REGRESS group.

de Maat MP, Kastelein JJ, Jukema JW, Zwinderman AH, Jansen H, Groenemeier B, Bruschke AV, Kluft C.

Arterioscler Thromb Vasc Biol. 1998 Feb;18(2):265-71. Review.

10.

Drugs that delay the progression of coronary atherosclerosis.

Ferraro-Borgida M, Waters D.

Cardiologia. 1997 Feb;42(2):149-61. Review. No abstract available.

PMID:
9090160
11.

[Antiatherogenic effects of angiotensin converting enzyme inhibitors from positions (point of view) of evidence based medicine. Part I].

Preobrazhenskiń≠ DV, Batyraliev TA, Peresypko MK, Pershukov IV, Sidorenko BA.

Kardiologiia. 2006;46(3):57-63. Review. Russian.

PMID:
16710258
12.

Electron beam computed tomography: calcification and lipid lowering interventions.

Budoff MJ.

Z Kardiol. 2000;89 Suppl 2:130-4. Review.

PMID:
10769416

Supplemental Content

Support Center